Cardiomyopathy News
- Heart Transplant Mortality Worse for Younger Black Adults
- Did Unrecognized Cardiac Amyloidosis Hinder Recent HFpEF Trials?
- STICH: Ischemia Not Linked to 10-Year Mortality, CABG Benefit
- Racial Disparities in Cardiovascular Outcomes for Pregnant and Postpartum Women
- New Gains in COVID-19 Science 1 Year Into the Pandemic
- Growth Hormone Recipients Face Small Increase in Heart Risks
- COVID-19 Case Fatality Doubled in Heart Transplant Patients
- Joint Guidelines Favor Antibody Testing for Lyme Disease
- New HCM Guidelines Make Shared Decision-making Top Priority
- AHA 2020 COVID-19 Outcomes Tied to Hospital, Not Just Race
- AHA 2020 Combined OCT, Cardiac MRI Unravels Root Cause in Most MINOCA
- AHA 2020 GALACTIC-HF: New 'Myotropic' Class Has Modest HFrEF Benefit
- Five Pediatric Heart Health Practices That May Be Unnecessary
- New Return-to-Play Recommendations for Athletes With COVID-19
- Mostly Positive Outcomes After 2018 Adult Heart Transplant Allocation Changes
- AAP 2020 When Should Students Resume Sports After a COVID-19 Diagnosis?
- COVID-19: Thromboembolic Events High Despite Prophylaxis
- Fellowship Training and COVID: Obstacles and Opportunities
- CDER Chief Reflects on Advances in Rare Diseases
- HFSA 2020 Cell Therapy for Anthracycline Cardiomyopathy Safe, Feasible